Alexander Michael Grandits

7PUBLICATIONS
18CO-AUTHORS
Solid tumoursMolecular targetsPredictive and prognostic markersAircraft performance and flight control systemsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 10, 2024
SKA1 promotes oncogenic properties in oral dysplasia and oral squamous cell carcinoma, and augments resistance to radiotherapy.

Alexander Michael Grandits, Barbara Andrea Reinoehl, Renate Wagner

|Oct 29, 2023
CTPS1 is a novel therapeutic target in multiple myeloma which synergizes with inhibition of CHEK1, ATR or WEE1.

Christina Pfeiffer, Alexander M Grandits, Hélène Asnagli

|Feb 15, 2022
EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells.

Alexander Michael Grandits, Sophie Bromberger, Gerwin Heller

|Mar 30, 2021
Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness.

Alexander Michael Grandits, Chi Huu Nguyen, Angela Schlerka

|Oct 01, 2020
Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells.

Chi Huu Nguyen, Alexander M Grandits, George S Vassiliou

|Sep 09, 2020
All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells.

Chi H Nguyen, Alexander M Grandits, Louise E Purton

Pageof 2

Frequent Collaborators

6 joint publications

Rotraud Wieser

4 joint publications

Chi Huu Nguyen

3 joint publications

Gerwin Heller

2 joint publications

Heinz Sill